These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2568094)

  • 1. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.
    Wolkin A; Barouche F; Wolf AP; Rotrosen J; Fowler JS; Shiue CY; Cooper TB; Brodie JD
    Am J Psychiatry; 1989 Jul; 146(7):905-8. PubMed ID: 2568094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients.
    Yousef KA; Volkow ND; Schlyer DJ; Fowler JS; Wolf AP; Wang GJ; Smith MR; Brodie JD; Warner D
    Synapse; 1995 Jan; 19(1):14-7. PubMed ID: 7709339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.
    Smith M; Wolf AP; Brodie JD; Arnett CD; Barouche F; Shiue CY; Fowler JS; Russell JA; MacGregor RR; Wolkin A
    Biol Psychiatry; 1988 Apr; 23(7):653-63. PubMed ID: 2967093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.
    Crawley JC; Crow TJ; Johnstone EC; Oldland SR; Owen F; Owens DG; Smith T; Veall N; Zanelli GD
    Nucl Med Commun; 1986 Aug; 7(8):599-607. PubMed ID: 2946010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
    Fitzgerald PB; Kapur S; Caligiuri MP; Jones C; Silvestri S; Remington G; Zipursky RB
    Neuropsychopharmacology; 2000 Jan; 22(1):19-26. PubMed ID: 10633487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol.
    Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD
    J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic cocaine abuse on postsynaptic dopamine receptors.
    Volkow ND; Fowler JS; Wolf AP; Schlyer D; Shiue CY; Alpert R; Dewey SL; Logan J; Bendriem B; Christman D
    Am J Psychiatry; 1990 Jun; 147(6):719-24. PubMed ID: 2343913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
    Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W
    Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone.
    Mazière B; Loc'h C; Baron JC; Sgouropoulos P; Duquesnoy N; D'Antona R; Cambon H
    Eur J Pharmacol; 1985 Aug; 114(3):267-72. PubMed ID: 3877639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
    Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
    Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.
    Baron JC; Mazière B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet AM; Agid Y
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):131-6. PubMed ID: 3485639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
    Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
    Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol.
    Schlyer DJ; Volkow ND; Fowler JS; Wolf AP; Shiue CY; Dewey SL; Bendriem B; Logan J; Raulli R; Hitzemann R
    Synapse; 1992 May; 11(1):10-9. PubMed ID: 1604422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH; Dasberg H; Ebstein RP
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Solin O; Haaparanta M; Ruotsalainen U; Rinne UK
    J Neurosci Res; 1990 Dec; 27(4):494-9. PubMed ID: 1981915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.